Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

Also called NCT07078071

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 199 participants (enrolled count) (from the registry)
Sponsor
Huawei Device Co., Ltd (from the registry)
Registry
  • NCT NCT07078071
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07078071. Non-randomized; single masking; primary purpose diagnostic. Start 2022-10-18 (actual); primary completion 2023-03-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
Condition
Arrhythmia, Heart
Intervention (Device)
ECG (electrocardiogram)
Lead sponsor
Huawei Device Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07078071
Content hash
81c4a9a53f4dc799c5a216bf5df0e79fdca80502ab181b73b682f016343e22e4